Merendree Pharma
ActiveSummary
Merendree Pharma has been active since 2013 and the Belgian Official Gazette contains no insolvency or warning signals. The 2026 annual accounts show equity of €264,470 and a net result of €60,077. Equity is growing by about 9.3% per year across the filed financial years. Its solvency ranks better than 77% of 490 sector peers (NACE 47, financial year 2026). The computed 12-month bankruptcy probability is 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2027, expected by
2026
12-10
NBB filing
Annual accounts filed
financial year 2026 · abbreviated format
30-06
Financial
Highest result from 2019 to 2026net €60,077 ▲3.7%
Net result €60,077, the highest in the series.
2025
09-12
NBB filing
Annual accounts filed
financial year 2025 · abbreviated format
2024
29-12
NBB filing
Annual accounts filed
financial year 2024 · abbreviated format
2023
27-11
NBB filing
Annual accounts filed
financial year 2023 · abbreviated format
10-11
Gazette deed
Resignations: Wim Mattelin, Isabelle Goossens and Céline MATTELINAppointment: Céline MATTELIN (enige niet statutaire bestuurder) · Amendment of the articles · Legal form clause16 facts ▸
Gazette deed
Resignations: Wim Mattelin, Isabelle Goossens and Céline MATTELIN
Appointment: Céline MATTELIN (enige niet statutaire bestuurder) · Amendment of the articles · Legal form clause16 facts ▸
- General meeting, 07-11-2023
- Amendment of the articles (2 times)
- Legal form clause, “TWEEDE BESLUIT, besloten vennootschap” (deed in Dutch)
- Capital conversion, “statutair onbeschikbare eigen vermogensrekening” (deed in Dutch)
- Reserve release, “opheffing, middelen beschikbaar voor uitkering” (deed in Dutch)
- Registered office clause, “verwijzing naar adres geschrapt uit artikel 2, 9850 Deinze (Merendree),Veldestraat 65 E” (deed in Dutch)
- Other provision, “besloten vennootschap, nieuwe terminologie WVV sinds 2020-01-01” (deed in Dutch)
- Director resignation, Wim Mattelin (statutory manager)
- Director resignation, Isabelle Goossens (statutory manager)
- Director resignation, Céline MATTELIN (manager (not named in the articles))
- Director appointment, Céline MATTELIN (enige niet statutaire bestuurder)
- Capital
- +4 further facts in this act
2022
08-12
NBB filing
Annual accounts filed
financial year 2022 · abbreviated format
30-06
Financial
Equity above €200,000equity €228,816 ▲15%
A profit in every financial year since 2019 builds equity to €228,816.
2021
02-12
NBB filing
Annual accounts filed
financial year 2021 · abbreviated format
30-06
Financial
Weakest financial yearnet €25,370 ▼30.4%
Net result drops to €25,370, the lowest in the series; recovery starts the following year.
2020
08-12
NBB filing
Annual accounts filed
financial year 2020 · micro format
30-06
Financial
Equity above €150,000equity €180,085 ▲25.4%
A profit in every financial year since 2019 builds equity to €180,085.
Show earlier events
2019
20-11
NBB filing
Annual accounts filed
financial year 2019 · micro format
2018
16-11
NBB filing
Annual accounts filed
financial year 2018 · micro format
2017
17-11
NBB filing
Annual accounts filed
financial year 2017 · micro format
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 13 annual accounts filed, the latest 10 are here; all 13 are under Financials.
1 of 4 deeds read
About the unread acts
Of the 4 Belgian Official Gazette deeds we know for this company, 1 has been read. The other 3 have not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.